Cellular senescence as a tumor-suppressor mechanism

Trends in Cell Biology

Volumn 11, Issue 11, 2001, Pages

  Campisi, Judith ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN P53; PROTEIN PRB; UNCLASSIFIED DRUG;

CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; GROWTH INHIBITION; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION;

ANIMALS; CELL AGING; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; PHENOTYPE; RETINOBLASTOMA PROTEIN; TELOMERE;

EID: 0035500487     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(01)02151-1     Document Type: Review

References (31)

1. Replicative senescence: Implications for in vivo aging and tumor suppression
2. Cancer, aging and cellular senescence
3. Replicative senescence and cell immortality: The role of telomeres and telomerase
4. Telomere states and cell fates
5. DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle arrest
6. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14/ARF tumor suppressor
7. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
8. Senescence of human fibroblasts induced by oncogenic raf
9. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
10. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts
11. Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide treated fibroblasts
12. Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening
13. Tumor suppressors and oncogenes in cellular senescence
14. Genes involved in senescence and immortalization
15. Regulation of cellular senescence by p53
16. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19/ARF) and is amplified in a subset of human breast cancers
17. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
18. PML is induced by oncogenic ras and promotes premature senescence
19. Two posttranscriptional pathways that regulate p21(Cip1/Waf1/Sdi1) are identified by HPV16-E6 interaction and correlate with life span and cellular senescence
20. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
21. The oncogene and Polycomb-group bmi-1 regulates cell proliferation and senescence through the ink4a locus
22. mdm2: A bridge over two tumour suppressors, p53 and Rb
23. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts
24. Mouse models in tumor suppression
25. Reducing mammary cancer risk through premature stem cell senescence
26. Extended life span and immortalization of human fibroblasts induced by X-ray irradiation
27. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging
28. Creation of psoriatic plaques: The ultimate tumor suppressor pathway
29. Microarray analysis of replicative senescence
30. Stress-induced secretion of growth inhibitors: A novel tumor suppressor function of p53
31. Effects of p21/Waf1/Co1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence and age-related diseases